Illustrative image – not actual.Cipla,
the pharmaceutical company plans to set up new units to manufacture insulin,
intravenous drugs and anti-cancer medicines in Goa.
The
company plans to invest about Rs.50 crore ($10.2 million) on these projects.
Funds for research and development projects are expected to be generated from
operating cash and from small bonds.
